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Abstract
Background:  Rheumatoid arthritis has varied pleuroparenchymal manifestations. Wegener's
granulomatosis can develop in an established case of rheumatoid arthritis and this association
although previously reported is very rare.
Case presentation: A 60-year-old lady had been diagnosed with rheumatoid arthritis on the basis
of her clinical symptoms and serological tests which were positive RA factor and anti-CCP
antibodies. Her rheumatoid arthritis activity had been mild and well controlled with
hydroxychloroquine and low dose prednisone. She presented with a productive cough and right-
sided pleuritic chest pain. CT scan of the chest showed three lung nodules with increased uptake
on PET CT scan, raising concerns for an inflammatory or malignant process. The differential
diagnosis included rheumatoid nodules, infections or malignancy. A CT-guided needle biopsy of the
largest nodule was undertaken which showed vasculitis typical of Wegener's granulomatosis. Stains
and cultures of the biopsy specimen were negative for bacteria, fungi and acid fast bacilli. A panel
of serological tests for vasculitis were checked and showed elevated titers of cANCA and anti-
proteinase 3 antibodies. Urine analysis and CT scan of paranasal sinuses was normal. Since the
upper respiratory tract and the kidneys were spared a diagnosis of limited Wegener's
granulomatosis affecting only the lungs was made. Due to the toxicity of cyclophosphamide, her
relatively mild disease sparing the kidneys and the underlying rheumatoid arthritis, weekly
methotrexate was started and low dose prednisone was continued. She had marked symptomatic
improvement and complete resolution of the nodules was documented on subsequent imaging.
Conclusion: Wegener's granulomatosis developing in a patient with rheumatoid arthritis is very
rare but should be considered as it warrants a different and possibly more aggressive treatment
approach.
Introduction
Rheumatoid arthritis (RA) is a systemic inflammatory dis-
order that has pleuroparenchymal involvement with var-
ied manifestations, which includes organizing
pneumonia, interstitial fibrosis, rheumatoid nodules, air-
way disorders such as bronchiectasis and bronchiolitis
and pulmonary vasculitis. Although the development of
Wegener's granulomatosis (WG) in a patient with pre-
existing RA is rare, it can occur as autoimmunity is the
basis of collagen vascular diseases. We present a rare case
of limited Wegener's granulomatosis presenting only as
lung nodules in a patient with RA.
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Case presentation
A 60-year-old lady presented with a one-week history of
shortness of breath, low-grade fever and right-sided pleu-
ritic chest pain. She had been treated with azithromycin
for presumed bronchitis with no improvement. She had
RA factor positive rheumatoid arthritis diagnosed about 3
years prior and was doing well with hydroxychloroquine
and low dose prednisone. Her other medical problems
included osteopenia, gastroesophageal reflux disease and
hypercholesterolemia for which she was on weekly risedr-
onate, calcium and vitamin D supplements, omeprazole
and atorvastatin respectively.
On examination her vital signs were stable, she was afe-
brile and her oxygen saturation was 95% on room air. She
appeared tired but not in any distress. Auscultation of the
lungs revealed wheezes bilaterally and few crackles at the
right base. The remainder of her examination was unre-
markable. She did not have any synovitis in the joints at
this time and range of motion was normal in all joints
with no muscle wasting. Skin examination showed some
old hypopigmented macules over her neck and face. There
were no skin nodules.
Her white count was 7.8 × 109/l with neutrophils of 84%.
The ESR by Westergren's method was 46 mm at the end of
one hour. A comprehensive metabolic profile was normal
and urine analysis did not show any sediment. Her chest
radiograph showed streaky infiltrates at the right base. A
high resolution CT scan showed three lung nodules (Fig
1). An FDG PET scan was done which showed avid uptake
in all the nodules with an SUV value of 8 (Fig 2). A CT-
guided lung biopsy of the right lung nodule was per-
formed. The lung biopsy showed fibrosis with acute and
chronic inflammation and necrotizing vasculitis (Fig 3).
Biopsy specimen examined for aerobic and anaerobic bac-
teria, acid fast bacilli and fungus, was negative on smear
and culture. A complete vasculitis panel was obtained
which included antinuclear antibodies, anti-dsDNA, anti-
Smith, anti-SSA and SSB, anti-histone antibody, anti-Jo-1,
anti-centromere antibody, anti Scleroderma -70, anti-pro-
teinase 3 and anti-myeloperoxidase antibodies along with
the antineutrophil cytoplasmic antibodies (ANCA). The
only positive tests were an elevated cANCA in a titer of 1:
640 (Normal less than 1: 20) and anti-proteinase 3 anti-
bodies of 118 units (Normal 0 – 20 units).
A screening CT scan of the sinuses was normal. A two-
dimensional echocardiogram showed a left ventricular
High resolution CT scan of the chest showing the lung nod- ules Figure 1
High resolution CT scan of the chest showing the 
lung nodules.
PET CT scan of chest showing increased uptake in nodules Figure 2
PET CT scan of chest showing increased uptake in 
nodules.
Histopathology of lung biopsy showing vasculitis Figure 3
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ejection fraction of 55% and normal pulmonary artery
pressures. Based on the biopsy and the serological find-
ings, a diagnosis of limited Wegener's granulomatosis pre-
senting as lung nodules was made.
Methotrexate was started and the low-dose prednisone
was continued. Her symptoms improved dramatically
with these and a repeat CT scan of the chest obtained one
month after treatment showed regression in the size of the
nodules and one done 3 months later showed complete
resolution of the same. She will be followed closely for
development of kidney or upper respiratory tract involve-
ment and monitored for methotrexate toxicity.
Discussion
The differential diagnosis of lung nodules in this patient
would include bronchiolitis obliterans organizing pneu-
monia, rheumatoid nodules, malignancy including lym-
phoma, and infections such as tuberculosis. The
necrotizing vasculitis in the biopsy specimens and the
positive cANCA indicated WG co-existent with the RA.
The presence of RA is confirmed by the erosive arthritis in
the joints of her hands and positive RA and anti CCP anti-
bodies at the time of diagnosis.
She developed WG in addition to her preexisting RA,
which is very rare, with only several cases reported so far
[1-4]. In the reported cases the majority were women and
RA preceded WG in all cases except one.
Based on the anatomic ELK classification [5] (E for ear,
nose and throat, L for lung and K for kidney) of Wegener's
granulomatosis, she appeared to have the L type with lung
involvement only with sparing of the kidney and the
upper respiratory tract. Lung involvement in Wegener's
granulomatosis may manifest as lung nodules, which are
often cavitary, acinar shadows which may represent alve-
olar hemorrhage, mediastinal lymphadenopathy and
pleural effusions. Traditionally the treatment of WG has
been cyclophosphamide-based regimens; however these
are limited by the toxicity of this drug, which may mani-
fest as bone marrow suppression, infections, cystitis, mye-
lodysplasia and bladder cancer [6]. The risk of cancer
directly depends on the cumulative dose of cyclophospha-
mide. The European Vasculitis Study Group [7] compared
the use of azathioprine after achieving remission with
cyclophosphamide versus treatment with cyclophospha-
mide for the entire duration of treatment and they found
that the rate of relapse did not differ significantly in the
two groups who were followed up to 18 months. Thus the
duration of treatment with cyclophosphamide can be
safely reduced. In non life threatening WG or when critical
organs are not involved, methotrexate may be used to
achieve remission of the disease but the relapse rate is
higher which may necessitate longer than 12 months of
treatment [6,8]. The lung being one of the critical organs,
if our patient had presented with pulmonary alveolar
hemorrhage, cyclophophamide pulses would have been
appropriate. But lung nodules being a relatively benign
manifestation of WG, cyclophosphamide may be used
initially to induce a remission after which azathioprine,
methotrexate or leflunomide may be used as maintenance
therapy to prevent relapses. We chose methotrexate for
our patient and continued low dose prednisone that she
tolerated well. Methotrexate would likely also benefit in
controlling the activity of her RA as well.
Although she has limited WG, there are reports of omi-
nous complications such as the development of complete
heart block [9] and hence she will be closely monitored
for those as well as for progression to the more severe
form involving the kidneys.
Conclusion
WG developing in patients with RA although very rare is
possible and should be considered when necrotizing vas-
culitis and cANCA positivity is seen. WG that does not
involve the kidneys or other vital organs can be treated
with less toxic regimes with methotrexate or azathioprine.
Limited WG may progress to involve kidneys and other
organs and hence should be clinically monitored. As
autoimmune dysfunction is the postulated mechanism in
connective tissue disorders, these may coexist in the same
patient. Thus clinicians should have a low threshold for
keeping these in their differential diagnosis.
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